UBS Group’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.61M | Sell |
53,449
-1,983
| -4% | -$59.6K | ﹤0.01% | 3994 |
|
|
2025
Q1 | $1.58M | Sell |
55,432
-14,080
| -20% | -$402K | ﹤0.01% | 3857 |
|
|
2024
Q4 | $2.3M | Buy |
69,512
+7,918
| +13% | +$262K | ﹤0.01% | 3607 |
|
|
2024
Q3 | $2.3M | Sell |
61,594
-6,619
| -10% | -$247K | ﹤0.01% | 2919 |
|
|
2024
Q2 | $2.29M | Sell |
68,213
-20,311
| -23% | -$682K | ﹤0.01% | 2728 |
|
|
2024
Q1 | $3.16M | Buy |
88,524
+10,725
| +14% | +$383K | ﹤0.01% | 2587 |
|
|
2023
Q4 | $2.56M | Sell |
77,799
-717
| -0.9% | -$23.6K | ﹤0.01% | 2618 |
|
|
2023
Q3 | $2.14M | Sell |
78,516
-4,464
| -5% | -$122K | ﹤0.01% | 2496 |
|
|
2023
Q2 | $2.62M | Sell |
82,980
-7,668
| -8% | -$242K | ﹤0.01% | 2468 |
|
|
2023
Q1 | $2.46M | Sell |
90,648
-338
| -0.4% | -$9.19K | ﹤0.01% | 2410 |
|
|
2022
Q4 | $2.76M | Sell |
90,986
-86,457
| -49% | -$2.63M | ﹤0.01% | 2294 |
|
|
2022
Q3 | $5.35M | Sell |
177,443
-4,963
| -3% | -$150K | ﹤0.01% | 1669 |
|
|
2022
Q2 | $5.05M | Sell |
182,406
-39,164
| -18% | -$1.08M | ﹤0.01% | 1767 |
|
|
2022
Q1 | $7.45M | Buy |
221,570
+30
| +0% | +$1.01K | ﹤0.01% | 1643 |
|
|
2021
Q4 | $9.36M | Sell |
221,540
-5,496
| -2% | -$232K | ﹤0.01% | 1592 |
|
|
2021
Q3 | $10.3M | Buy |
227,036
+34,268
| +18% | +$1.56M | ﹤0.01% | 1479 |
|
|
2021
Q2 | $9.43M | Sell |
192,768
-11,435
| -6% | -$559K | ﹤0.01% | 1555 |
|
|
2021
Q1 | $10.3M | Buy |
204,203
+5,759
| +3% | +$289K | ﹤0.01% | 1429 |
|
|
2020
Q4 | $10.2M | Sell |
198,444
-2,763
| -1% | -$142K | ﹤0.01% | 1381 |
|
|
2020
Q3 | $8.28M | Sell |
201,207
-2,991
| -1% | -$123K | ﹤0.01% | 1386 |
|
|
2020
Q2 | $8.54M | Sell |
204,198
-13,659
| -6% | -$571K | ﹤0.01% | 1280 |
|
|
2020
Q1 | $6.91M | Sell |
217,857
-18,833
| -8% | -$597K | ﹤0.01% | 1300 |
|
|
2019
Q4 | $10M | Sell |
236,690
-2,261
| -0.9% | -$95.6K | ﹤0.01% | 1491 |
|
|
2019
Q3 | $7.54M | Sell |
238,951
-24,902
| -9% | -$786K | ﹤0.01% | 1557 |
|
|
2019
Q2 | $9.53M | Buy |
263,853
+3,937
| +2% | +$142K | ﹤0.01% | 1415 |
|
|
2019
Q1 | $9.4M | Sell |
259,916
-123
| -0% | -$4.45K | ﹤0.01% | 1387 |
|
|
2018
Q4 | $7.32M | Sell |
260,039
-187,187
| -42% | -$5.27M | ﹤0.01% | 1447 |
|
|
2018
Q3 | $17.6M | Buy |
447,226
+76,161
| +21% | +$3M | 0.01% | 1022 |
|
|
2018
Q2 | $13.8M | Buy |
371,065
+151,354
| +69% | +$5.64M | 0.01% | 1150 |
|
|
2018
Q1 | $7.52M | Buy |
219,711
+41,006
| +23% | +$1.4M | ﹤0.01% | 1549 |
|
|
2017
Q4 | $5.86M | Buy |
178,705
+16,283
| +10% | +$534K | ﹤0.01% | 1716 |
|
|
2017
Q3 | $5.06M | Buy |
162,422
+7,180
| +5% | +$224K | ﹤0.01% | 1731 |
|
|
2017
Q2 | $4.33M | Buy |
155,242
+39,806
| +34% | +$1.11M | ﹤0.01% | 1799 |
|
|
2017
Q1 | $2.97M | Buy |
115,436
+57,984
| +101% | +$1.49M | ﹤0.01% | 2022 |
|
|
2016
Q4 | $1.32M | Buy |
57,452
+26,262
| +84% | +$602K | ﹤0.01% | 2616 |
|
|
2016
Q3 | $814K | Buy |
31,190
+22,447
| +257% | +$586K | ﹤0.01% | 2858 |
|
|
2016
Q2 | $198K | Buy |
8,743
+3,370
| +63% | +$76.3K | ﹤0.01% | 3742 |
|
|
2016
Q1 | $117K | Buy |
5,373
+1,553
| +41% | +$33.8K | ﹤0.01% | 4123 |
|
|
2015
Q4 | $121K | Sell |
3,820
-7,970
| -68% | -$252K | ﹤0.01% | 4101 |
|
|
2015
Q3 | $329K | Buy |
11,790
+7,926
| +205% | +$221K | ﹤0.01% | 3377 |
|
|
2015
Q2 | $137K | Buy |
3,864
+3,036
| +367% | +$108K | ﹤0.01% | 4104 |
|
|
2015
Q1 | $25K | Buy |
+828
| New | +$25K | ﹤0.01% | 5200 |
|